Intellectual Property Magazine
Novartis’ Sandoz buys Aspen Pharmacare’s Japanese IP
South African drug company Aspen Pharmacarehas confirmed it has sold the IP of its Japanese arm to Novartis’ Sandoz.
South African drug company Aspen Pharmacarehas confirmed it has sold the IP of its Japanese arm to Novartis’ Sandoz.